CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
March 2nd 2022, 4:00pm
Guidelines for the treatment of patients with brain metastases is moving from whole brain radiation therapy to less toxic treatment options to potentially improve care and increase survival.
February 4th 2022, 10:00pm
After four years of additional follow-up, survival continued to improve and side effects remained tolerable in patients with anaplastic thyroid cancer receiving Tafinlar plus Mekinist.
February 4th 2022, 4:00pm
From the death of a former New York Mets player due to cancer, to a lawsuit against Tokyo Electric Power Company Holdings regarding cancer potentially caused by the 2011 Fukushima nuclear disaster, here’s what’s happening in the cancer landscape this week.
October 14th 2021, 3:00pm
“We tried very hard, my daughter and I, to have a daughter-father relationship, not a daughter-doctor relationship,” said Dr. Michael Weiner on this episode of the “CURE® Talks Cancer” podcast, in which he discussed his career, his own cancer journey and his daughter’s diagnosis.
September 22nd 2021, 7:00pm
The tome also reflects on his own diagnosis of cancer and how it influenced his practice.
September 22nd 2021, 4:05pm
The FDA approval of Cabometyx was based on results that showed that the drug was associated with improved outcomes in patients with radioactive iodine–refractory locally advanced or metastatic differentiated thyroid cancer.
September 20th 2021, 10:30pm
View the full CURE® Educated Patient® Webinar: Treatment and Care for Thyroid Cancer on demand.
July 28th 2021, 2:04pm
Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.
July 28th 2021, 1:58pm
The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.
July 21st 2021, 5:48pm
Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.
How to Access Support Resources for Rare Cancers
The Defining Moments of Support After Hearing ‘You Have Cancer’
Off-the-Shelf Immunotherapy May Offer Benefits in Kidney Cancer
Gleevec Associated With Long-Term Effectiveness in Treating GIST